ADIL CIK: 1513525

Adial Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−11.2
FY23:
−6.81
FY24:
−6.92
FY25:
−6.49
Change from FY21 to FY25
millions USD
FY21:
−0.03
FY22:
–
FY23:
1.50
FY24:
–
FY25:
0.15
Change from FY21 to FY25
millions USD
FY21:
13.6
FY22:
9.13
FY23:
4.13
FY24:
7.85
FY25:
8.47
(positive)
millions USD
FY21:
−12.0
FY22:
–
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR